Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.KYNB · Entity 7431 | Chief Financial Officer | September 06, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date September 06, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,355 |
Reported balance
After 2026-09-06 transaction · row 1
1 source rowRow 1 · 2026-09-06 · Tax withholding · Disposed 22 · Balance 4,355 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 10, 2026 00:41 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 22 | $8.55 | $188.10 |
DisclosureSEC source: 0002040705-26-000007 · form4-09102026_120933.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,355 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 21:44 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 52 | $6.71 | $348.92 |
DisclosureSEC source: 0002040705-26-000005 · form4-06092026_090631.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,377 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:40 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 60 | $6.84 | $410.40 |
DisclosureSEC source: 0002040705-26-000003 · form4-03102026_090314.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,429 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 02:06 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0002040705-26-000002 · form4-02062026_020236.xml · derivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The option vests in equal amount quarterly over 4 years measured from 2/3/2026. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 21:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 52 | $8.42 | $437.84 |
DisclosureSEC source: 0002040705-25-000002 · form4-12092025_091258.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,489 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 23:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 53 | $12.10 | $641.30 |
DisclosureSEC source: 0001415889-25-024014 · form4-09092025_110911.xml · nonDerivative · entry 2 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,541 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2025 Filed Sep 9, 2025 23:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 51 | $7.83 | $399.46 |
DisclosureSEC source: 0001415889-25-024014 · form4-09092025_110911.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,594 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:01 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,325 | $0.39 | $906.75 |
DisclosureSEC source: 0001415889-25-007455 · form4-03082025_120327.xml · nonDerivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,137 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| January 09, 2025 Filed Jan 10, 2025 23:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 525,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001415889-25-001312 · form4-01102025_110123.xml · derivative · entry 1 DeLucia David · CIK 0002040705 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,000 Underlying: Common Stock · 525,000 shares Expires 2035-01-08 F1 · derivative.exercise_date: The option vests in equal amount quarterly over 4 years measured from 1/9/2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.